In the multivariate analysis, IGF-1 levels lower than 56 ng/mLremained a significant risk factor for poorer OS (HR, 1.889; 95% CI, 1.128–3.163; P = 0.02), together with BCLC stage, larger tumor size, and mRECIST non-responders. Here, IGF1 is linked to neoplasm.